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Abstract
Background: HIV susceptibility linked to hormonal contraception (HC) has been studied before,
but with mixed results. Recent findings have prompted the World Health Organisation (WHO), to
encourage women who use HC to concurrently use condoms in order to prevent HIV infection in light
of possible increased HIV risk of infection associated with hormone based contraceptives.
Methods and Findings: A two sex HIV model classifying women into three risk groups consisting
of individuals who use condoms, natural methods and hormone based contraceptives is formulated and
analysed to assess the effects of various birth control methods on the transmission dynamics of the
disease. Our model results showed that women who use HC could be key drivers of the epidemic and
that their increased infectivity may be critical in driving the epidemic. Women who use hormone based
contraceptives potentially act as a core-group from which men get infected and in turn transmit the
disease to other population groups. We fitted the model to HIV prevalence data for Zimbabwe reported
by UNAIDS and Zimbabwe Ministry of Health and Child welfare (MoHCW) and used the model fit to
project HIV prevalence. Predictions using HIV data for Zimbabwe suggest that a hypothesised increase
in susceptibility and infectivity of 2, 3, and 4 fold would result in a 25%, 50% and 100% increase in
baseline HIV prevalence projection respectively, thus suggesting possible increased disease burden even
in countries reporting plausible HIV prevalence declines.
Conclusion:Although a possible causal relationship between HIV susceptibility and HC use remains
subject of continuing scientific probe, its inclusion as part of birth control strategy, has been shown
in this study, to possibly have significant influence on HIV transmission. If proven, HC use may
potentially explain the inordinate spread of HIV within the sub-Saharan Africa region and therefore
compel for urgent assessment with a view to reorienting birth control methods in use in settings with
generalised epidemics.
Key words: Hormonal contraceptives, heightened HIV transmissions, reproductive number, stability,
model fitting.
1 Introduction
Despite declining birth and increasing death rates due to AIDS, sub-Saharan Africa’s population has
doubled to 620 million, in less than 25 years and is projected to double again within thirty years [72]. A
tenth of the world’s female population lives in sub-Saharan Africa, but the region accounts for 40% of
the world’s 215, 000 annual pregnancy-related deaths [72]. Sub-Saharan Africa is home to only 11% of
the world’s population, yet by the close of 2001, it was habitat to 70% of the world’s 40 million people
living with HIV/AIDS [43]. Unfortunately there is no evidence that blending of AIDS education into
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family planning and maternal health services is taking place. Studies in 10 sub-Saharan countries [72],
showed that health staff discuss sexually transmitted diseases with only 1 in 10 family planning clients
and AIDS with just 1 in 14 and yet such services often are the only contact women have with the health
system. An important opportunity for educating women about protecting themselves from HIV and
AIDS is thus missed. In sub-Saharan Africa, 23% of married women are using family planning, 18% with
a modern method, 5% with a traditional method [24] and 25% reporting that they would prefer to stop
having children or delay their next birth, but are not using any method of family planning. The average
contraceptive prevalence in this region (22%), is less than half that of South Asia (53%) and less than a
third that of East Asia (77%) [89].
Diverse birth control strategies are practised in the region. The natural (traditional) method of birth con-
trol which is menstrual cycle dependent, is favoured and often prescribed as the only correct one among
some religious groups. In Kenya studies showed that the probability of a woman using family planning
services if she was Catholic was 28% lower than that of women with different religious background such
as Protestant and Muslim [69]. Yeatman and Trinitapoli [90], however showed that Muslims were the
least likely to use injectables, pills, Intra Uterine Devices or condoms. Some churches discourage faithfuls
from using contraceptives as birth control measures and instead encourage them to rely more on the
natural method [69] and expressly forbid the use of barrier methods of contraception such as condoms
while treating emergency contraception such as the morning-after pill as a means of abortion [12]. Nearly
30% of women in sub-Saharan Africa do not use birth control as they are either opposed to contraception,
unaware of options, have problems with access or believed they were not fertile [2] and would prefer birth
control methods with no contraceptive effects, were compatible with infrequent sex and whose use would
be non-detectable to their sex partner. Barrier methods involve the use of rubber products that prevent
the exchange of mucosal fluids during intercourse and the most commonly used are condoms. Hormonal
methods of birth control involve the ingestion or the contraceptive injection of a substance whose main
ingredient is progesterone administered via a tablet or some liquid. Andreea et al. [14], showed that
short term family planning methods involving contraceptives were more popular (6% of women between
the ages of 15 and 49 having used injectables) compared with long term methods, with the pill being
favoured by teenagers, women who are cohabiting, women with no children and women with at least
a college education. Women in the richest wealth quintile were more likely than those in the poorest
quintile to practice long-term contraception such as intrauterine devices, implants and sterilisation.
The UN, at its 2000 summit set the improvement of maternal health by 2015 as its 5th MDG [79].
This was to be achieved through provision of universal access to reproductive health. Combating of
HIV/AIDS by halting and reversing its spread by 2015 was adopted as the 6th MDG. Evidence that the
use of HC methods to attain maternal health for all by 2015 could be impacting negatively on efforts
to combat HIV spread in the region that suffers most from unintended pregnancies (59%) [73] and high
HIV prevalence rates in excess of 10% [77,78,80–82] pose a new dilemma and challenges to global devel-
opment [25]. The implications are not palatable given that the region is aﬄicted with high maternal and
neonatal mortality rates which make access to contraception a necessity. As early as 2004, HC use was
already being cited as a possible risk factor for HIV transmission [88]. According to recent studies [28,70],
women who use hormonal methods of birth control such as the pill or the contraceptive injection had a
significantly higher risk of HIV-1 seroconversion. Heffron et al. [28] reported two fold increases in the
risks of both HIV acquisition and HIV transmission among women in HIV discordant couples. Results
of an analogous study in macaques [50] showed that female rhesus macaques with progesterone implants
were 7.7 times more likely to be infected with simian immunodeficiency virus than macaques that had
a placebo implant. Other studies reporting increased risk of HIV acquisition in women and possible
increased risk of female-to-male HIV transmission include [3, 40, 45, 65–67,70].
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However results from studies by [37, 38, 62] reported no association between HIV acquisition risk and
use of injectable contraception. The dichotomy in the results is amplified by discrepancies in study
design, contraceptive method studied, sample sizes, analytic methods used, and the complexity of inter-
preting results across these observational studies [26]. In a systematic review [67], four of nine studies
considered informative but with important limitations reported a 1.5 to 2.2 times increased risk of HIV
acquisition in women using injectable contraception(DMPA) [3, 28, 56, 87]. The remaining five studies of
injectable contraception in the review [39, 57, 62, 71] reported no statistically significant association with
risk of HIV acquisition. In the same review [67], only one study reported increased risk of acquisition
resulting from the use of oral contraceptive pills (OCPs).
Women who took injectable contraceptives had raised concentrations of HIV genetic material in their
cervical secretion [28] and this could be the mechanism for passing on the virus to a sexual partner.
Injected in the form of tiny crystals suspended in solution, DMPA gradually seeps into the bloodstream,
duping a woman’s body into thinking she is already pregnant and thus halting ovulation. Thus a woman’s
defenses against disease may then be lowered in the same manner akin to pregnancy. The thinning of the
vaginal mucosa by progesterone has been reported to make it easier for HIV to penetrate the vaginal wall
in an uninfected woman, and, conversely, for an HIV-positive woman to infect her partner [86]. Other
possible suggestions were that Depo-Provera could result in the reduction of the production of hydrogen
peroxide producing lactobacilli which in turn could decrease vaginal acidity as well as cause irregular
uterine bleeding [4, 52]. Progesterone and oestrogen may accentuate recruitment of inflammatory and
other target cells to the genital tract [54] although this is considered a very new area of research [27].
In view of this increasing conflicting literature on the link between HC use and heightened HIV trans-
mission and acquisition risk, WHO experts convened a meeting to review existing literature on the
subject [84]. The UN body ruled that available data was insufficient and did not establish a clear causal
link between heightened HIV acquisition and transmission and the use of HCs. However they also con-
ceded that available evidence could not conclusively rule out the possibility of an association. Hence
its current recommendation for women to continue using HCs to avoid unplanned pregnancies while en-
couraging women at risk of or living with HIV to use condoms concurrently to prevent HIV infection or
transmission. While debate on the HIV link to Depo-Provera rages, we are compelled to develop a novel
theoretical HIV model that incorporates, the dynamics of reproductive health in sub-Saharan Africa and
includes possible accentuated HIV risks due to HC use, in order to understand how these affect disease
transmission dynamics. HIV models that combine biological and social aspects of populations in sub-
Saharan Africa, such as birth control, alcohol consumption [47, 75] and gender inequality [61] are poised
to improve our understanding of the disease. To the best of our knowledge, no mathematical modelling
studies of the possible dynamic influence of HC use on HIV transmission have been carried out and ours
is pioneering work in assessing the potential dynamic impact on HIV transmission of HC use in high HIV
prevalence settings.
2 Model development
We develop a deterministic compartmental model that classifies the heterosexually active male popula-
tion into three classes: susceptibles Sm(t), containing individual males who are not infected with the
virus, Im(t), containing individual males who are infected with the virus but have yet to develop AIDS
symptoms and Am(t), are individual male AIDS cases exhibiting specific clinical features related to the
disease. Susceptible females, and infectives who have sero-converted but are yet to progress to AIDS
are categorised according to the contraceptive method used. Susceptible females and infectives who use
condoms for birth control are denoted by Sfc and Ifc respectively. Conversely, susceptibles and infectives
who use the natural method of contraception are denoted by Sfn and Ifn respectively and those who use
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HC are denoted by Sfh and Ifh depending on whether they are infected or not. Females who show clini-
cal features of the disease are categorized in the AIDS class Af and are assumed to be nonreproductive.
At any moment in time, new recruits enter the heterosexually active population at a constant rate Λ.
A proportion φ of susceptible individuals are assumed to be female and the complementary proportion
(1 − φ), are male. A proportion δ1, δ2 and δ3 of new female recruits enter the class of women who use
condoms Sfc , women who use the natural method Sfn and women who use HC methods Sfh of birth con-
trol respectively. It is assumed that a woman will use one method of birth control throughout
her reproductive lifetime and that the reproductive lifetime equates to her mean sexual life
time. Men can choose any sexual partner irrespective of their contraceptive method. The time dependent
force of infection for females who use condoms for birth control is given by λfc(t), and that for females
who use the natural method is given by λfn(t). Females that use HC acquire infection at time dependent
force of infection λfh(t). Similarly susceptible males acquire infection at time dependent rate λm(t).
The infection rate depends on the probability of transmission by an infecting partner (βj), frequency of
partner acquisition, (ci) where i, j = (fc, fn, fh,m), i 6= j (refers to male or female and excludes same sex
interaction) and the proportion of infected individuals in each category. Females who use condoms as
a method of birth control confer protection from HIV to their partners and themselves. The protective
effect of condom use on HIV transmission is modelled by 1 − pc where pc = ǫψ, with the parameters ǫ
and ψ modeling condom efficacy and consistency respectively. Females who use HC are more susceptible
to the virus at a relative measure of susceptibility χ > 1 [28,70] and they are at increased risk of passing
on the virus to their partner at a relative measure of infectivity θ > 1 [28].
Following the approach in [10, 33, 34, 47] on the mixing pattern, we let qij be the preference of peo-
ple in group i to have a partner in group j, then qij is the fraction of people in group j that a person in
group i desires to form a partnership with. Further details on the formulation of partnership formation
and preferences can be found in [9, 11, 16, 20, 30, 36, 63]. If we assume an unlimited number of potential
partners then the probability that a partnership forms (mutually accepted rate of sex) between people
in group i and people in group j, ρij is given by ρij = qijqji. Let ci be the number of contacts for an
individual in group i, and assuming that mixing is random but constrained by the activity levels [63],
the probability that a contact in group i is with a person in group j is given by
cjNj∑
k ckNk
where k is the
number of classes and Nk = Sk + Ik is the total sexually interactive population. The probability of a
partnership forming between people in group i and j is then given by
ρijcjNj∑
k ckNk
. The force of infection
for susceptible people in group i is thus given by
λi =
K∑
j=1
ρijβj
cjIj∑
k ckNk
. (1)
where βj is the probability of being infected by an individual in group j and cj is the rate of acquiring
sexual partners in group j. The number of contacts made by people in group i with people in group j
must essentially be equal to the number of contacts made by people in group j with people in group i
and therefore the ρij ’s and ci’s must satisfy the following balance equation,
cjρji
Ni
=
ciρij
Nj
. (2)
Thus the total number of contacts made in unit time by members of group i with members of group j is
ciρijNj and because this must equal the total number of contacts by members of group j with members
of group i, the following balance relations hold
cfcNfcρfcm = cmNmρmfc , cfnNfnρfnm = cmNmρmfn , cfhNfhρfhm = cmNmρmfh , (3)
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where Nfc , Nfn , and Nfh are the respective female populations that use condoms, normal birth control
methods and HC methods and Nm is the total sexually interacting male population. Equation (3) implies
that the number of contacts with men reported by users of condoms for birth control must equal the
number of sexual contacts reported by men with females who use condoms for birth control. Assuming
cj = ck that is sexual activity is independent of birth control method used, then the balance law in
equation (2) can be written as
cf
Nm
=
cm
Nfcρfcm +Nfnρfnm +Nfhρfhm
.
We use birth control as the risk factor and therefore women select their partners without discrimination.
Thus qim = qi and ρij = qiqmi and thus ρfcm = ρmfc = qfqmfc , ρfnm = ρmfn = qfnqmfn and ρmfh =
qfhqmfh where qfc , qfn and qfh is the desire, by females who use condoms, females who use the natural
method and females who use HC methods of birth control respectively, to form partnerships with males
and qmfc , qmfn and qmfh measures male desires, to form partnerships with females who use condoms,
natural methods and HCs respectively. The mixing assumptions lead to the following forces of infection
for the different groups.

λm(t) = βfcm
ρmfc(1− pc)Ifc(t) + ρmfnIfn(t) + ρmfhθIfh(t)
Nf (t)
,
λfc(t) = ρfcm(1− pc)cfβm
Im(t)
Nm(t)
,
λfn(t) = ρfnmcfβm
Im(t)
Nm(t)
,
λfh(t) = ρfhmχcfβm
Im(t)
Nm(t)
,
(4)
where Nj is the total sexually active population in sex category j (excluding AIDS patients who are
assumed to be symptomatic and therefore incapable of new partnership formation). Upon becoming
infected with HIV, female and male susceptibles enter the classes Ifc , Ifn , Ifh and Im of infected indi-
viduals, respectively. In the context of Zimbabwe whose data we will use for model fitting, we assumed a
constant emigration rate α > 0 of individuals to other countries except for the AIDS patients because the
country faced increased emigration due to more than a decade of economic meltdown. Infected individu-
als in each class progress to AIDS at a constant rate γ > 0. The natural death rate µ > 0 is assumed to
be proportional to the number in each class. AIDS patients have an additional disease-induced mortality
rate, ν > 0. In this study we ignore the population which uses long-term methods such as the intrauter-
ine devices, implants and sterilisation, as studies have shown this population to be very small [14] (in
sub-Saharan Africa). The model flow diagram is depicted in Figure 1.
The model assumptions and formulations described result in the following deterministic compartmen-
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tal model.
dSfc(t)
dt
= δ1φΛ− λfcSfc(t)− (µ+ α)Sfc(t),
dSfn
dt
(t) = δ2φΛ− λfnSfn(t)− (µ+ α)Sfn(t),
dSfh(t)
dt
= δ3φΛ− λfhSfh(t)− (µ+ α)Sfh(t),
dIfc(t)
dt
= λfcSfc(t)− (γ + µ+ α)Ifc(t),
dIfn(t)
dt
= λfnSfn(t)− (γ + µ+ α)Ifn(t),
dIfh(t)
dt
= λfhSfh(t)− (γ + µ+ α)Ifh(t),
dAf (t)
dt
= γ(Ifc(t) + Ifn(t) + Ifh(t))− (µ+ ν)Af (t),
dSm(t)
dt
= (1− φ)Λ− λmSm(t)− (µ+ α)Sm(t),
dIm(t)
dt
= λmSm(t)− (γ + µ+ α)Im(t),
dAm(t)
dt
= γIm(t)− (µ+ ν)Am(t).


(5)
In the following sections, we will mix analytical and numerical techniques to present a detailed analysis of
the model which is followed by fitting of the model to HIV prevalence for Zimbabwe using data reported
by UNAIDS [76] and MoHCW [91].
3 Model basics
Theorem 1. Given Sfc(0) > 0, Sfn(0) > 0, Sfh > 0, Ifc(0) > 0, Ifn(0) > 0, Ifh > 0, Af (0) > 0, Sm(0) >
0, Im > 0 and Am(0) > 0 the solutions
(
Sfc(t), Sfn(t), Sfh(t), Ifc(t), Ifn(t), Ifh(t), Af (t), Sm(t), Im(t) and Am(t)
)
of model system (5) are positively invariant for all t > 0.
Proof. Let t1 = sup(t > 0|Sfc > 0, Sfn > 0, Sfh > 0, Ifc > 0, Ifn > 0, Ifh > 0, Af > 0, Sm > 0, Im >
0, Am > 0). From the first equation S
′
fc
(t) = δ1φΛ − (λfc(t) + µ + α)Sfc(t) from which the integrating
factor is given by exp
{∫ t
0
λfc(s)ds + (α + µ)t
}
. Multiplying the first equation by the integrating factor
we obtain the following equation
d
dt
[
Sfc(t) exp
{∫ t
0
λfc(s)ds+ (α+ µ)t
}]
= δ1φΛexp
{∫ t
0
λfc(s)ds+ (α+ µ)t
}
. (6)
Solving this equation, we obtain
Sfc(t) exp
{∫ t
0
λfc(s)ds+ (α+ µ)t
}
− Sfc(0) =
∫ t
0
δ1φΛexp
{∫ τ
0
λfc(p)dp+ (α+ µ)p
}
dτ (7)
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from which we deduce that
Sfc(t) = Sfc(0) exp−
{∫ t
0
λfc(s)ds
+(α+ µ)t
}
+ exp−
{∫ t
0
λfc(s)ds+ (α+ µ)t
}
.
∫ t
0
δ1φΛexp
{∫ τ
0
λfc(p)dp+ (α+ µ)p
}
dτ ≥ 0
(8)
Similarly, it can be shown that (Sfn(t) > 0, Sfh(t) > 0, Ifc(t) > 0, Ifn(t) > 0, Ifh(t) > 0, Af (t) >
0, Sm(t) > 0, Im(t) > 0, Am(t) > 0.)
Theorem 2. The region D = W ∪M ⊂ R7+ × R3+ is positively-invariant for model system (5) with
non-negative initial conditions in R10.
Proof. We analyse model system (5) in a biologically-feasible region as follows. Consider the
feasible region: D =W ∪M ⊂ R7+ × R3+, where
W =
{
Sfc , Sfn , Sfh , Ifc , Ifn , Ifh , Af ∈ R7+
}
and
M =
{
Sm, Im, Am ∈ R3+
}
.
Summation of the first seven and the last three equations of model system (5) yields
φΛ− µW(t)− αNf t− νAf (t),
(1− φ)Λ− µM(t)− αNm(t)− νAm(t).
(9)
Since(
Af (t) ≤ Nf (t) ≤M(t)
)
, then from equation (9) it follows that
φΛ− (µ+ α+ ν)W(t) ≤ dW(t)
dt
≤ φΛ− µW(t). (10)
Hence
φΛ
(µ+ α+ ν)
≤ lim inf
t→∞
W(t) ≤ lim sup
t→∞
W(t) ≤ φΛ
µ
(11)
and therefore lim supt→∞W(t) ≤
φΛ
µ
. In a similar fashion, we can show that lim supt→∞M(t) ≤
(1− φ)Λ
µ
. Using a standard comparison theorem [42], it can be shown that
W(t) ≤ W(0)e−µt + φΛ
µ
(1− e−µt) and M(t) ≤M(0)e−µt + (1− φ)Λ
µ
(1− e−µt). Particularly M(t) ≤
φΛ
µ
if W(0) ≤ φΛ
µ
and M(t) ≤ (1− φ)Λ
µ
if M(0) ≤ (1− φ)Λ
µ
. The region D is thus positively-
invariant and it is sufficient to consider the dynamics of the flow generated by model system
(5) in D. In this region, the model can be considered as being epidemiologically and
mathematically well-posed [29]. Thus, every solution to model system (5) with initial
conditions in D remains in D for all t > 0.
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3.1 Disease-free equilibrium
In order to analyse and understand the time evolution of an epidemic, typically, one studies the equilibria
and their associated stability using an epidemic threshold value called the reproductive number. Setting
the right hand side of model system (5) to zero, we obtain the disease-free equilibrium ξ0 as
ξ0 =
(
S0fc , S
0
fn , S
0
fh
, S0m, I
0
fc , I
0
fn , I
0
fh
, I0m, A
0
f , A
0
m
)
=
( δ1φΛ
(α+ µ)
,
δ2φΛ
(α+ µ)
,
δ3φΛ
(α+ µ)
,
(1− φ)Λ
(α+ µ)
, 0, 0, 0, 0, 0, 0
)
.
(12)
We define the birth control induced reproductive number RH as the expected number of secondary cases
produced, in a completely susceptible population, by a typical infective individual when introduced into
a population using condoms, traditional and HC methods. If RH > 1 the disease will successfully invade
a population and an epidemic occurs, while RH < 1 precludes invasion. An associated threshold, R0
is defined as the basic reproductive number for the community in the absence of birth control. We use
the approach in [18, 85] and the reproductive number RH is defined as the spectral radius of the next
generation matrix FV −1 [85], from which we deduce the dominant eigen value RH ,
RH =
√
cfcmβfβm[ρ
2
mfc
(1− pc)2δ1 + ρ2mfnδ2 + ρ2mfhθχδ3]
(α+ γ + µ)2
= R0H. (13)
The quantity H =
√
ρ2mfc(1− pc)2δ1 + ρ2mfnδ2 + ρ2mfhθχδ3 is the heterogeneity brought about by use of
different birth control measures.
3.2 Stability of disease-free equilibrium
The following result follows from [85].
Lemma 1. The disease-free equilibrium of model system (5) is locally asymptotically stable if RH < 1,
and unstable if RH > 1.
In Lemma 1 we stated that if RH < 1, the fixed point ξ0 is locally asymptotically stable. We now
investigate the global asymptotically properties of the disease-free equilibrium.
Theorem 3. The disease-free equilibrium of model system (5) is globally asymptotically stable for RH < 1
on D.
Proof. Consider the Lyapunov function
V(t) = a1Ifc + b1Ifn + c1Ifh + d1Im (14)
where a1, b1, c1 and d1 are constants to be determined. The time derivative along the solution path of
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V(t) yields
d
dt
V(t) =


=
[
a1 ˙Ifc + b1
˙Ifn + c1
˙Ifh + d1
˙Im
]
,
= a1
[
ρmfc(1− pc)cfβm
Im
Nm
Sfc − (γ + µ+ α)Ifc
]
+b1
[
ρmfncfβm
Im
Nm
Sfn − (γ + µ+ α)Ifn
]
+c1
[
ρmfhχcfβm
Im
Nm
Sfh − (γ + µ+ α)Ifh
]
+d1
[
ρmfc(1− pc)cmβf
Ifc
Nf
Sm + ρmfncmβf
Ifn
Nf
Sm + ρmfhθcmβf
Ifh
Nf
Sm − (γ + µ+ α)Im
]
,
=
[
a1ρmfc(1− pc)cfβm
Sfc
Nm
+ b1ρmfncfβm
Sfn
Nm
+ c1ρmfhχcfβm
Sfh
Nm
− d1(γ + α+ µ)
]
Im
+
[
d1ρmfc(1− pc)cmβf
Sm
Nf
− a1(γ + α+ µ)
]
Ifc
+
[
d1ρmfncmβf
Sm
Nf
− b1(γ + α+ µ)
]
Ifn
+
[
d1ρmfhθcmβf
Sm
Nf
− c1(γ + α+ µ)
]
Ifh ,
≤
[
a1ρmfc(1− pc)cfβmSfc + b1ρmfncfβmSfn + c1ρmfhχcfβmSfh − d1(γ + α+ µ)
]
Im
+
[
d1ρmfc(1− pc)cmβfSm − a1(γ + α+ µ)
]
Ifc
+
[
d1ρmfncmβfSm − b1(γ + α+ µ)
]
Ifn
+
[
d1ρmfhθcmβfSm − c1(γ + α+ µ)
]
Ifh .
(15)
Setting the coefficients of Ifc , Ifn and Ifh to zero and solving for b1, c1 and d1 we obtain
b1 =
a1ρmfn
(1− pc)ρmfc
c1 =
θa1ρmfh
(1− pc)ρmfc
d1 =
(α+ γ + µ)a1
cm(1− pc)Smβfρmfc


.
Substituting for the constants and equilibrium relations of Sfc , Sfn , Sfh and Sm into equation (15), we
obtain
d
dtV(t) ≤
a1
(1− p)ρmfc
[
−(α+ µ)(α+ γ + µ)
2
Λ(1− φ)cmβf +
Λφcfβm
(
(1− p)2δ1ρ2mfc + θχδ3ρ2mfh + δ2ρ2mfn
)
(α+ µ)
]
Im
≤ a1
(1− p)ρmfc
(α+ γ + µ)
cmβf
[
R2H − 1
]
Im
≤ 0, ifRH < 1,
(16)
for the relation
Nm
Nf
=
(1− φ)
φ
which is valid at the disease free equilibrium. Using the Lyapunov stability
theorem
d
dt
V(t) is negative definite. The omega limit set of each solution is the largest invariant set for
which Sfc = S
∗
fc
, Sfn = S
∗
fn
, Sfh = S
∗
fh
, Sm = S
∗
m, Ifc = 0, Ifn = 0, Ifh = 0, Im = 0 for which E0 is a
singleton. By LaSalle’s invariance principle [44], the disease-free equilibrium E0 is globally asymptotically
stable in D. This achieves the proof.
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By Theorem 3 if on average every individual infects less than one other individual then they fail to
replenish themselves and disease prevalence will be a decreasing function of Ii(t) and the disease dies out
regardless of the initial levels of the epidemic. Global stability of the disease-free equilibrium implies that
if RH < 1, HIV will be eliminated from the community.
3.3 Endemic equilibrium
Model system (5) has an endemic equilibrium point derived in terms of the force of infection given by,
ξ∗ =


S∗fc =
Λφδ1
(K2 + λ∗fc)
, S∗fh =
Λφδ2
(K2 + λ∗fn)
, S∗fn =
Λφδ3
(K2 + λ∗fh)
, S∗m =
Λ(1− φ)
(K2 + λ∗m)
,
I∗fc =
Λφδ1λ
∗
fc
K1(K2 + λ∗fc)
, I∗fn =
Λφδ2λ
∗
fn
K1(K2 + λ∗fn)
,
I∗fh =
Λφδ3λ
∗
fh
K1(K2 + λ∗fh)
, I∗m =
Λ(1− φ)λ∗m
K1(K2 + λ∗m)
,
where K1 = (α+ γ + µ) and K2 = (α+ µ) with
λ∗m = βfcm
ρmfc(1− pc)I∗fc + ρmfnI∗fn + ρmfhθI∗fh
N∗f
, λ∗fc = ρfcm(1− pc)cfβm
I∗m
N∗m
,
λ∗fn = ρfnmcfβm
I∗m
N∗m
and λ∗fh = ρfhmχcfβm
I∗m
N∗m
.
After several algebraic manipulations shown in Appendix A, we obtain, a quatic polynomial f(λ∗m)
expressed in terms of λ∗m as follows
f(λ∗m) = A1λ∗m4 +A2λ∗m3 +A3λ∗m2 +A4λ∗m (17)
from which the following solutions are obtained,
λ∗m = 0, (18)
λ∗m =
24/3A5(√
A2
6
−4A3
5
−A6
)1/3 + 22/3(√(A26 − 4A35)1/3 −A6)− 2A2
6A1 , (19)
λ∗m =
27/3A5(√
A2
6
−4A3
5
−A6
)1/3 +√A26 − 4A351/3 − 4A2
12A1 , (20)
λ∗m =
27/3A5(√
A2
6
−4A3
5
−A6
)1/3 −√A26 − 4A351/3 − 4A2
12A1 , (21)
with 

A5 = A22 − 3A1A3
A6 = 2A32 − 9A1A2A3 + 27A21A4.
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Equation (18) represents model system (5) at the disease-free equilibrium whose qualitative properties
have already been resolved in Sections 3.1. In order to show existence of endemic equilibria for model
system (5) it is necessary that we show that one of the solutions to λ∗m in equations (19,20,21) is positive
for the condition RH > 1 but that exercise is a laborious task. Instead using parameter values in Table
2 we plot the graphs of λ∗m in equations (19,20,21) to show existence of endemic equilibria. The plot of
λ∗m in equation (19) is shown in Figure 2 and depicts an epidemic or forward bifurcation curve [19]. The
graph of λ∗m in equations (20,21) exists in the negative octant of λ
∗
m and denotes imaginary populations
that are not biologically feasible and therefore of no interest to us. From Figure 2 we deduce the following
lemma:
Lemma 2. Model system (5) has a unique endemic equilibrium which exists for RH > 1 and does not
exist otherwise.
Consistent with standard results in HIV models, the forward bifurcation curve has, no positive endemic
equilibria for RH < 1 and a low level of endemicity when RH is slightly above 1 [19]. In our previous
work, [47] we showed that RH >
√
2 was sufficient condition (which is more burdensome than RH > 1)
for HIV endemicity. The implication from that result and result from Figure 2 is that at RH = 1 disease
control is feasible and this is important result for resource constrained communities such as exist in sub-
Saharan Africa. In Figure 2, the black bold line represents a stable disease-free equilibrium for RH < 1,
and the blue line represents a stable endemic equilibrium point when RH > 1, with low endemicity noted
for RH close to 1. In the event that the disease-free equilibrium exists for RH > 1, then it is a saddle and
is depicted by the red broken line. Away from the vicinity of RH = 1, the epidemic size is an increasing
function of the birth control induced reproductive number hence a forward bifurcation manifests. The
same process to show the existence of the endemic equilibrium point can be repeated by analysing the
conditions of existence for λ∗fc , λ
∗
fn
and λ∗fh . It is straight forward to show the local stability of the endemic
equilibrium using the center manifold theorem [46,47].
3.4 Global stability of the endemic equilibrium
Results in Lemma 2 suggest the existence of an endemic equilibrium point ξ∗ which destabilises the
disease-free equilibrium ξ0 and is locally stable whenever RH > 1. In Theorem 4 we state conditions for
its global stability and the proof is given in Appendix B.
Theorem 4. If RH > 1, the endemic equilibrium state ξ∗ ∈ D exists and is globally asymptotically stable
in D if
S∗fcIfc = SfcI
∗
fc , S
∗
fnIfn = SfnI
∗
fn , S
∗
fh
Ifh = SfhI
∗
fh
, S∗mIm = SmI
∗
m.
Serious implications regarding HIV/AIDS dynamics emanate from the global stability of the endemic
equilibrium. For RH > 1, the implication is that the disease persists irrespective of the initial conditions.
The onerous task for policy makers therefore is the reduction of the reproductive number to below unit
in order to destabilise the endemic equilibrium and control the epidemic.
4 Numerical analysis and results
In order to explore qualitative features of our model through numerical simulations, we used data from
sub-Saharan Africa. Transmission parameters are key components in any HIV modeling study. Hetero-
sexual HIV transmission is estimated to have a very low probability [22], but due to confounding effects
of cofactors that differ, it varies within regions. Cuadros et al [15] showed that a single value for HIV
infectivity is inappropriate and fails to describe the dynamics of the epidemic in sub-Saharan Africa.
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They concluded that the inclusion of individual variation generated by transient yet repeated increases
in HIV viral load associated with co-infections may provide a biological basis for the widespread and
accelerated spread of HIV in sub-Saharan Africa. Further, results in [5] showed that the proportion of
men reporting that they have had 2 or more sex partners in a year ranged from 1% to 28% in sub-Saharan
Africa. In other studies, [74] it was shown that the mean number of lifetime sexual partners ranged from
3.4 to 12.9 with a mean of 6.3 in sexually active men in the region. Mean lifetime number of partners of
men in the immediate local community was predictive of hazard of HIV acquisition in women. Recent
evidence suggests that the adult HIV-1 latent period may be shorter in some sub-Saharan African popu-
lations than in Western populations [22] and we assumed an average incubation period of between 4 to 10
years. A Runge-Kutta algorithm of order 4 coded in Matlab is used to carry out numerical simulations
to illustrate some of the analytical results given in this paper, to investigate some qualitative features of
our HIV/AIDS model, determine the effect of different parameters on the model and to fit our model to
HIV prevalence data for Zimbabwe. We carried out sensitivity analysis on model system (5) to determine
important model parameters using baseline values picked from HIV literature given in Table 2.
4.1 Sensitivity analysis
Parameter values used for model system (5) are estimates from different studies and therefore are unre-
liable since their actual values are not known. Sensitivity analysis is necessary because of the structural
complexity of the model which is coupled with lack of certainty when estimating input parameters [6].
To account for this uncertainty in parameter input values, we use a statistical analysis technique (Latina
Hypercube Sampling (LHS)) that allows simultaneous random variation of all the input parameters [48].
The range is divided into n intervals each with equal chance. Each random variable is then assigned a
probability density function. Thus there are n observations for each of the k parameters [53]. For one
sample point xi, a random selection is made on x1 and paired with a random selection on x2, x3...xk
and this constitutes the first sample point. The process is repeated n times to give the first sample. A
sensitivity analysis may then be performed by calculating partial rank correlation coefficients (PRCC) for
each input parameter (sampled by the LHS scheme) and each outcome variable [6]. A PRCC quantifies
the degree of influence of each parameter on each response while holding the influence of other param-
eters constant. A monotonic relationship between the response variables and the model parameters is
assumed [32] in PRCC analysis. A PRCC is bounded between −1 and 1. Values near the magnitude 1
indicate a dominant parameter in influencing the response while the least important rank parameters are
close to zero.
The PRCC analysis requires a monotonically increasing function [32], hence our use of the combined
AIDS cases A, (A = Af +Am) to find the dominant input parameters. It is possible though that certain
parameters might exhibit non-monotonic relationships with the output variable and consequently have a
low PRCC but may produce huge changes in the outcome variable [6] and different model structures will
give different sensitivity analysis results and similar PRCC results may not be obtained from other model
structures. Parameters unrelated to the disease were excluded from the analysis that is the natural birth
and death rates and the emigration rate. The baseline values associated with the response variable A are
tabulated in Table 2 and these parameters are assumed to be independent and come from a uniform dis-
tribution. The uniform distribution is useful when only the minimum and maximum range of a parameter
is estimable [8] or when there is no evidence that the end of the ranges are less probable than the middle
values [53]. If evidence points to the later, then a triangular distribution is more appropriate [8]. We
used the observations from the LHS to calculate PRCCs between the response variable A and fourteen
constituent parameters of the birth control induced reproductive number. Scatter plots were generated
and studied to check that the assumption of monotonicity was satisfied and some of these are shown in
Figure 3. The PRCCs are shown in Table 1.
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In Table 1 the most influential parameters on the number of AIDS cases are those with p < 0.001.
These are (i) the progression rate to AIDS γ, (ii) the increased infectivity of females who use HCs θ,
(iii) the male partnership acquisition parameter cm, (iv) increased susceptibility of females due to con-
traceptive use χ, and (v) the mutually accepted rate of sex between males and females who use HCs
ρmfh
. Three of these parameters are related to HC use. The increased infectivity of females who use
contraceptives (θ) as birth control mechanism, has the greatest influence on the number of AIDS cases
followed by the number of male partnerships. The parameter that represents increased susceptibility due
to contraceptive use is next in importance followed by the mutual rate of sex between males and females
that use HCs. The magnitude of the PRCC for male and female infectivity relative to the PRCC values
of the other parameters related to HCs suggests that biological infectivity (βf , βm) is of lesser influence
in determining the number of AIDS cases a result which does not emphasise standard results and results
in [7, 47, 53] but emphasises the importance of parameters related to birth control. The mutual rate of
sex between men and contraceptive users plays a very significant role (as does βf and cf ) as shown by
the size of the PRCC. If contraceptive users become more preferable to men than condom users (may be
through sensation seeking), more AIDS cases will manifest. The uncertainties in estimating the values
of the parameters described above (θ, χ, cm, ρfhm, βf , βm, cf ), are the most critical in contributing to the
prediction precision (imprecision) of the number of HIV cases.
Sensitivity analysis is important in that it focuses data collection efforts [6] through identification of
the critical parameters (due to their estimation uncertainty) in the prediction precision (imprecision) of
future AIDS cases. The qualitative relationship between the input parameters and output variables is
shown by the signs of the PRCCs. The negative signs indicate that an increase in that input parameter
would result in the reduction of future AIDS cases and for an increase in the input parameters whose
PRCCs are positive, the reverse is analogous. The partial rank correlation coefficients that are shown
in Table 1 are plotted in Figure 4 and show qualitatively, the magnitude of the influence of the various
parameters in RH on the combined number of AIDS cases. We use a cut-off of p < 0.05 for statistical
significance of parameters on the model output. In Table 4 the PRCC for the parameter pc representing
condom use and parameters representing population proportions using particular birth control methods
(δ1, δ2, and δ3) and the mutual rate of sex between men and women who use condoms and natural meth-
ods, are very low showing that these parameters are not significant in the outcome. However these PRCCs
have p > 0.05, showing that it cannot be ruled out that chance factors are determining the relationship.
A description of parameters, their baseline values and fitted values of parameters with significant PRCCs
from Table 1 assuming no increased susceptibility of infectivity due HCs is given in Table 2. Using values
in Table 2, we showed the qualitative relationship between the birth control induced reproductive number
to some of its constituent components.
Figures 5(a) and 5(b) show that use of condoms and efficacy will reduce RH and also HIV prevalence
amongst users of barrier based methods of contraception. Condom efficacy has already been proven to
be very high (≈ 85%), and thus the only effort will be on scaling up its use. An increase in disease
susceptibility and infectivity through use of HCs will result in higher values of RH and hence disease
prevalence as shown by Figures 5(c) and 5(d).
4.2 Model fitting and predictions
In order to assess the potential impact of using HCs on HIV dynamics, we fit our model to Zimbabwe
HIV prevalence data. The first reported case of AIDS in Zimbabwe occurred in 1985. By the end of
the decade, although data was sparse, an estimated 10% of the adult population were thought to be
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infected with HIV [80]. In the first half of the 1990s, prevalence rose drastically, peaking at 28.5% in
1997 [83]. Therein, the HIV prevalence began to decline and the adult prevalence rate stood at 23.7%
in 2001 subsequently falling to 14.3% in 2010 [83]. A number of reasons have been proposed for this
decline including economic meltdown which resulted in the outward migration of infected persons to seek
medication outside the country. Using the current UNAIDS definition of prevalence Ii+AiSi+Ii+Ai , the effect of
AIDS deaths on prevalence is twofold. High AIDS deaths will either reduce prevalence or balance off new
birth rates thereby maintaining high previous prevalence rates. We address this problem by removing
AIDS cases from the numerator and denominator in our definition of prevalence and this is consistent
with our previous assumption that individuals in the AIDS category are non interactive and therefore are
unlikely to be observed using the current method which employees ante-natal clinics (although UNAIDS
data is readjusted to include AIDS cases). Secondly, high AIDS related deaths are also thought to have
resulted in reduced infectivity as people witnessed firsthand, the death of close relatives and friends
and this resulted in behaviour changes [23] leading to the reduction of incidence rates which in turn
would lower prevalence levels. Condom use has increased, and greater numbers are now delaying sexual
debutancy and reduction of partnership has been observed since 2005 [80]. At the start of the epidemic,
people that have lots of sex, are more likely to be infected quickly, while those that have infrequent sex,
might never be infected. For this reason, in our data fit we include behaviour change and allow for a
declining force of infection as the prevalence increases. As more people become symptomatic and visible
to society, at risk individuals tend to acquire greater HIV awareness, and we thus make the force of
infection responsive to this reduced susceptibility and make it a function of the symptomatic rate (γ) so
that the contact rate function is modelled by
ciβje
−̟γP
where the parameter ̟ is the response due to reducing susceptibility and due to experiential learning
resulting from people seeing individuals develop AIDS symptoms and P is the prevalence function. Such
modeling technique is used for data fitting in [31] but the authors use the number of AIDS deaths where
we have used prevalence.
UNAIDS reported HIV prevalence data from the year 1990 onwards and this marks our initial mod-
eling year. For the years 2008 and 2009, we used data estimates from MoHCW [91] with the rest coming
from UNAIDS [76]. At the start of the epidemic in 1990 we set our initial sub-population levels to depict
a prevalence level of 14% reported by UNAIDS [80] as at 1990. We employed least squares curve fitting
function in Matlab to fit our model to HIV prevalence data for Zimbabwe. In the fitting we estimated,
probabilities of HIV transmission (βf , βm), response for behaviour change (̟), incubation period γ and
emigration rate (α) and the estimated values are given in Table 2. Prevalence gives us the proportion of
infected persons in the population and together with the index of people living with HIV and AIDS allows
for forward planning. It however falls short in that it is affected by multiple factors such as progression
to AIDS and outward migration or high AIDS death rates balancing off new birth rates and therefore
maintaining high prevalence rates. Nowadays treatment may result in longevity of life while infected and
therefore lead to higher prevalence rates. More often for a better understanding of the epidemic path, it
is more insightful to obtain the actual number of new infections per unit time.
Plots of the prevalence and incidence functions are given in Figures 6 (a) and 6 (b). Assuming the
same conditions persist, we make projections for prevalence and incidence up to the year 2020 and these
are shown in Figures 6 (c) and 6 (d). The projections suggest that incidence curve will plateau below
0.01 from the year 2007.To estimate the potential impact of using HCs on HIV prevalence, we considered
a scenario without HC use (i.e. θ = χ = 1) and introduced their use in the year 2010. Using parameters
estimated from the best fit in Figure 6 (a) shown in Table 2, we projected HIV prevalence for different
susceptibility and infectivity levels due to HC use and also explored the impact of using condoms for
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optimistic scenarios (in Figure 7).
Results in Figure 7(a) show that projected HIV prevalence will increase by 25%, 50% and 100% from
the baseline epidemic levels when baseline values for susceptibility and infectivity (χ, θ) are simultane-
ously increased by 2, 3, and 4 fold respectively. Thus a potential increase in susceptibility and infectivity
due to HCs use has the capacity to increase HIV prevalence even in countries reporting plausible de-
clines in HIV prevalence such as Zimbabwe. Model projections in Figures 7(b) and (c) show the effects
of increasing female infectivity and susceptibility on HIV prevalence respectively due to HC. However if
HC use result in increased susceptibility only without commensurate increases in risk of infectivity to
men, disease prevalence would be high in the cohort of HC users but will remain unchanged in the gen-
eral population since contraceptive use is still limited to a small group of women in sub-Saharan Africa.
This scenario removes the bridging effect of men between the high-risk core group and low-risk general
population. Figure 7(d) shows that HIV prevalence would decrease by approximately 600% at a very
optimistic consistency of condoms use of 100% for birth control. Thus an opportunity exists for HIV
control through the use of condoms which save the dual purpose of birth control and HIV transmission.
5 Discussion and conclusion
While a straightforward causal link between HC use and heightened HIV transmission remains to be
demonstrated, preliminary evidence suggesting potential increased risk to HIV susceptibility and infec-
tivity due to HC use, [3,17,28,40,51,55,70], compels for the modelling of theoretical aspects and the what
if scenarios regarding the dynamic influence of HC use on HIV transmission. We designed a deterministic
compartmental model to provide perspectives on the dynamical interaction of HIV and the social and
biological aspects of reproductive health practiced by communities in sub-Saharan Africa. In order to
ensure that our model is at the confluence of theory and the real world, and provide both abstractive and
biological meaning, we fitted our model to HIV data for Zimbabwe and used the parameters that gave
the best fit to predict the implications of HC use on HIV prevalence.
Our results demonstrated the potential of HC use to compound the HIV epidemic. The model was
designed to include possible increases in susceptibility and infectivity due to HC use. Numerical results
showed that infectivity of women on HC may play a disproportionately prominent role in driving HIV dy-
namics (Figure 7 (b)). Depo-Provera users may cause heightened transmission to their male partners who
in turn act as a bridge and pass the virus on to the lower risk group of women. The more partners males
have, the more influential they become in driving the epidemic and the more HC use becomes important
in shaping HIV transmission dynamics. This result on male partner acquisition rate is standard [47], but
the result on infectivity suggesting heterosexual male infectivity to be less influential than female infec-
tivity in a model that incorporates birth control is novel. In other words HC use causes female infectivity
to become more significant in determining disease dynamics over male infectivity. Several studies have
shown male-female infectivity exceed female-male infectivity per each coital act [49,64], and these results
have been used to explain contrasting gender differentials in HIV prevalence. Our results show that when
HCs are used, female to male infectivity of HC users taken together with male partnership formation
rates, would become the key driver of the epidemic. Low HIV endemicity is noted for the cohort that uses
condoms for birth control, but overall condom use is shown to be insufficient in controlling the epidemic if
other birth control methods are employed by women. However if condoms are universally used as a birth
control tool, HIV control is feasible. This result is consistent with results in previous studies [1, 53, 68].
We fitted our model to prevalence data from Zimbabwe extracted from UNAIDS [76] and MoHCW [91]
from the years 1990 to 2010 (Figure 6 (a)). To estimate the potential impact of using HC on HIV
prevalence, we considered a scenario without HC use and introduced their use in the year 2010. When
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susceptibility and infectivity were increased simultaneously from the baseline case, the results suggest
that HIV prevalence in the year 2020 would increase by 25%, 50% and 100% respectively showing that
the potential increase of the use of DMPA would enlarge the epidemic and derail disease control efforts
(Figure 7 (a)). It is important to note that data used in the data fit spans 20 years. Substantial epidemi-
ological evolution would have taken place during that long time span including changes in susceptibility
and parameter values. We replaced the constant transmission coefficient with an exponentially decaying
function in order to reflect this reduction in susceptibility. However other aspects of the epidemiology
of HIV/AIDS such as treatment which affects the longevity of the infectivity period are salient features
of the fitted data but are not captured in the model. Certainly the HIV adjusted expected lifetime γ
at the start of the epidemic cannot be expected to be the same after the point of introduction of HIV
treatment and neither can be, the infectivity of individuals reported to be infected. The peak of the HIV
epidemic coincided with a severe economic recession with estimated range of more than 3 million people
to a few hundred thousand [21] having fled the economic meltdown that caused severe food shortages
and a collapse of the health system. In recent times, the economy has stabilised and free treatment is
provided locally by government agencies and migration for purposes of treatment is no longer a necessity
in Zimbabwe. However our model does have a parameter to capture outward migration of infectives.
Consequently, the parameters that give the best model fit are, infact, a smoothed average of different
facets characterising the epidemic through the period of data collection.
Our results suggest that while biological aspects about the disease itself, that is transmission related
parameters, play a significant role in influencing disease dynamics, they play a relegated role to param-
eters related to HC. Results from this study, although based on inconclusive evidence of the scientific
role of DMPA as a cause for accelerated HIV transmissions, reinforce the need for more effort and re-
sources to be put into further research to assess the potential impact of HC methods of birth control on
HIV transmission and the need for guidelines for women using family planning services in HIV endemic
settings. It is shown in this study that use of condoms for birth control, and protection against HIV
in general [53, 60], will result in lesser efforts being needed to fight the HIV epidemic (Figure 7 (d)).
Condemnation and limited use of HC which are cheap and easy to self administer would probably cause
increased maternal mortality and morbidity [28] and thus public health policy makers are already advo-
cating the reorientation of family planning programmes [35] with a view of promoting condoms whose
independent use has been shown to be effective at fighting HIV spread.
Our work is based on conflicting scientific evidence and must be upheld in a theoretical contextual
framework. Until a definite causal relationship between HC use and heightened HIV transmission is
established, recommendations by WHO advocating for individuals most at risk of HIV infection, to use
dual protection with condoms, should be taken seriously. Only then, in light of our modelling results,
can the specific transmission risk to men be highlighted together with their consequential potential to
spread the disease to the rest of the low risk general population.
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Appendix A
Substituting the values of S∗fc , S
∗
fn
, S∗fh , S
∗
m, I
∗
fc
, I∗fn , I
∗
fh
, I∗m into λ
∗
fc
, λ∗fn , λ
∗
fh
and λ∗m gives


λ∗fn =
cfβmλ
∗
mρfnm
(K1 + λ∗m)
,
λ∗fc =
(1− pc)cfβmλ∗mρfcm
(K1 + λ∗m)
,
λ∗fh =
χcfβmλ
∗
mρfhm
(K1 + λ∗m)
.
Using the relationship λ∗fc =
(1− pc)ρfmc
ρfmn
λ∗fn , λ
∗
fh
=
χρfmh
ρfnm
λ∗fn and λ
∗
fn =
cfβmλ
∗
mρfnm
(K1 + λ∗m)
and solving
for λ∗m where

A1 = K3K5K8δ2 +K4(K5K6δ1 +K3K7δ3),
A2 = K1(K2(K4K6δ1 +K5K6δ1 +K3K8δ2 +K5K8δ2 + (K3 +K4)K7δ3)
+K1(K4K5(Rh −R2H +Rn + δ1) +K3(K5(Rc +Rh −R2H + δ2) +K4(Rc −R2H +Rn + δ3)))),
A3 = K21K2(K1(K3(1 +Rc −R2H − δ1)−K4(−1 +R2H −Rn + δ2) +K5(1 +Rh −R2H − δ3)
+K2(K6δ1 +K8δ2 +K7δ3))),
A3 = K41K22(R2H − 1),
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and


K3 = (K2 + (1− pc)cfβmρfcm),K4 = (K2 + cfβmρfnm),K5 = (K2 + χcfβmρfhm),
K6 = (K1 + (1− pc)cfβmρfcm),K7 = (K1 + χcfβmρfhm),K8 = (K1 + cfβmρfnm),
Rn = δ2cfβmρfnmcmβfK2
1
,Rc =
δ1(−1 + pc)2cfcmβfβmρ2fcm
K2
1
,Rh =
δ3θχcfcmβfβmρ
2
fhm
K2
1
.
Further algebraic manipulations result in the following quatic function shown in equation (17) whose
solution is shown in equations (18),(19),(20) and (21).
Appendix B
Global stability of endemic equilibrium.
Proof. At equilibrium, the following relations hold
δ1φΛ = λ
∗
fc
S∗fc +K2S∗fc ,
δ2φΛ = λ
∗
fn
S∗fn +K2S∗fn ,
δ3φΛ = λ
∗
fh
S∗fh +K2S∗fh ,
(1− φ)Λ = λ∗mS∗m +K2S∗m,


and { K1I∗fc = λ∗fcS∗fc ,K1I∗fn = λ∗fnS∗fn ,
K1I∗fh = λ∗fhS∗fh ,K1I∗m = λ∗mS∗m,
Consider the candidate Lyapunov function V, such that,
V = Sfc − S∗fc − S∗fc ln
Sfc
S∗fc
+ Sfn − S∗fn − S∗fn ln
Sfn
S∗fn
+ Sfh − S∗fh − S∗fh ln
Sfh
S∗fh
+ Sm − S∗m − S∗m ln
Sm
S∗m
+Ifc − I∗fc − I∗fc ln
Ifc
I∗fc
+ Ifn − I∗fn − I∗fn ln
Ifn
I∗fn
+ Ifh − I∗fh − I∗fh ln
Ifh
I∗fh
+ Im − I∗m − I∗m ln
Im
I∗m
.
(B.1)
Clearly Sfc − S∗fc is an increasing polynomial and S∗fc ln
Sfc
S∗fc
is logarithmic function and using the same
argument on the rest of the variables the polynomial will outgrow the logarithmic function and therefore

V (Sfc , Sfn , Sfh , Sm, Ifc , Ifn , Ifh , Im) > 0, Sfc > S
∗
fc
, Sfn > S
∗
fn
, Sfh > S
∗
fh
, Sm > S
∗
m, Ifc > I
∗
fc
,
Ifn > I
∗
fn
, IfhI
∗
fh
, Im > I
∗
m,
V (S∗fc , S
∗
fn
, S∗fh , S
∗
m, I
∗
fc
, I∗fn , I
∗
fh
, I∗m) = 0
What is left is to prove that
V˙ < 0.
The time derivative of V along the solution path is given by
V˙ = ˙Sfc
[
1− S
∗
fc
Sfc
]
+ ˙Sfn
[
1− S
∗
fn
Sfn
]
+ ˙Sfh
[
1− S
∗
fh
Sfh
]
+ ˙Sm
[
1− S
∗
m
Sm
]
+ ˙Ifc
[
1− I
∗
fc
Ifc
]
+ ˙Ifn
[
1− I
∗
fn
Ifn
]
+ ˙Ifh
[
1− I
∗
fh
Ifh
]
+ ˙Im
[
1− I
∗
m
Im
.
] (B.2)
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Substituting equilibrium values and re-writing expressions for the derivatives of the state variables we
obtain the following system
˙Sfc = λ
∗
fc
S∗fc +K2S∗fc − λ∗fcS∗fc
λfcSfc
λ∗fcS
∗
fc
−K2S∗fc
Sfc
S∗fc
,
˙Ifc = λ
∗
fc
S∗fc
λfcSfc
λ∗fcS
∗
fc
−K1I∗fc
Ifc
I∗fc
,
˙Sfn = λ
∗
fn
S∗fn +K2S∗fn − λ∗fnS∗fn
λfnSfn
λ∗fnS
∗
fn
−K2S∗fn
Sfn
S∗fn
,
˙Ifn = λ
∗
fn
S∗fn
λfnSfn
λ∗fnS
∗
fn
−K1I∗fn
Ifn
I∗fn
,
˙Sfh = λ
∗
fh
S∗fh +K2S∗fh − λ∗fhS∗fh
λfhSfh
λ∗fhS
∗
fh
−K2S∗fh
Sfh
S∗fh
,
˙Ifh = λ
∗
fh
S∗fh
λfhSfh
λ∗fhS
∗
fh
−K1I∗fh
Ifh
I∗fh
,
˙Sm = λ
∗
mS
∗
m +K2S∗m − λ∗mS∗m
λmSm
λ∗mS
∗
m
−K2S∗m
Sm
S∗m
,
˙Im = λ
∗
mS
∗
m
λmSm
λ∗mS
∗
m
−K1I∗m
Im
I∗m
.


(B.3)
Substituting into equation (B.2), the re-arranged expressions for the derivatives of the state variables as
well as the equilibrium values of K1I∗fc ,K1I∗fn ,K1I∗fh and K1I∗m, we obtain the following expression,
V˙ =


λ∗fcS
∗
fc +K2S∗fc − λ∗fcS∗fc
λfcSfc
λ∗fcS
∗
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−K2S∗fc
Sfc
S∗fc
− λ∗fcS∗fc
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−K2S∗fc
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+ λ∗fcS
∗
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λ∗fc
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+λ∗fcS
∗
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λfcSfc
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∗
fn +K2S∗fn − λ∗fnS∗fn
λfnSfn
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∗
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∗
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∗
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λmSm
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∗
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−K2S∗m
Sm
S∗m
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S∗m
Sm
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S∗m
Sm
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∗
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λ∗m
+K2S∗m
+λ∗mS
∗
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λmSm
λ∗mS
∗
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Im
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∗
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∗
mIm
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∗
m.
(B.4)
Collecting like terms, the derivative reduces to
V˙ =


K2S∗fc
[
2− Sfc
S∗fc
− S
∗
fc
Sfc
]
+ λ∗fcS
∗
fc
[
1− Ifc
I∗fc
− S
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fc
Sfc
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∗
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1− SfcI
∗
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S∗fcIfc
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+K2S∗fn
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2− Sfn
S∗fn
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∗
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∗
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+K2S∗fh
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∗
fh
Sfh
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∗
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∗
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]
+ λ∗fhS
∗
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1− SfhI
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S∗fhIfh
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+K2S∗m
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2− Sm
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]
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m
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1− Im
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− S
∗
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Sm
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∗
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1− SmI
∗
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]
.
(B.5)
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Substituting equilibrium values in Theorem 4,
V˙ =


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]2
S∗fcSfc
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+ λ∗mS
∗
m
[
1− Im
I∗m
− S
∗
m
Sm
]
.
(B.6)
Based on the conditions for the validity of the candidate Lyapunov function Sfc > S
∗
fc
, Sfn >
S∗fn , Sfh > S
∗
fh
, Sm > S
∗
m, Ifc > I
∗
fc
, V˙ ≤ 0. We used the Lyapunov stability theorem to show that
V˙ < 0 for all
(S∗fc , S
∗
fn , S
∗
fh
, S∗m, I
∗
fc , I
∗
fn , I
∗
fh
, I∗m) > 0 ∈ D
and the strict equality V˙ = 0 holds only for Sfc = S
∗
fc
, Sfn = S
∗
fn
, Sfh = S
∗
fh
, Sm = S
∗
m, Ifc =
I∗fc , Ifn = I
∗
fn
, Ifh = I
∗
fh
and Im = I
∗
m. Then the only equilibrium state ξ
∗ is the only positively
invariant set of the endemic solution for model system (5) contained entirely in D and hence
by the asymptotic stability theorem in [44], the endemic equilibrium state ξ∗ is a sink. This
completes the proof.
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Figure 1: Model flow diagram showing the movement of people from Susceptible Si (blue in colour), Infected Ii
(pink in colour) to AIDS Ai (red in colour) classes. The two compartments denote male and female with the red
double arrows denoting heterogeneous sexual interaction.
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Figure 2: Plot of RH against λ∗m for varying values of βf increasing from 0 to 1 in step sizes of 0.1 and all other
parameters are as given in Table 2.
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Figure 3: Partial rank correlation coefficients scatter plots of some of the parameters in RH against the combined
number of female and male AIDS cases. The baseline parameter values are given in Table 2.
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Figure 4: Partial rank correlation coefficients showing the effect of varying the input parameters on the response
variable (combined female and male AIDS cases). All parameters with positive PRCCs will result in an increase
on the number of AIDS cases when increased while an increase in parameters with negative PRCCs will result in
reduced number of AIDS cases.
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Figure 5: Plots: (a) and (b) show RH against varying values of ǫ and ψ, (c) and (d) show RH against varying
values of θ and χ with other parameter values as given in Table 2.
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Figure 6: (a) Model fit to UNAIDS and MoHCW prevalence data for Zimbabwe. (b) Incidence curve corresponding
to the prevalence from our model fit to UNAIDS and MoHCW data for Zimbabwe. (c) HIV model projection of
prevalence till 2020. (d) HIV model projection of incidence till year 2020. UNAIDS and MoHCW data was used to
fit the model and parameter values giving the best fit are given in Table 2.
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Figure 7: (a) Time series plot of HIV prevalence for increasing susceptibility and infectivity due to HC use from
baseline case (θ, χ) = 1 to 2, 3 and 4 in the direction of the arrow. (b) Time series plot of HIV prevalence for
increasing infectivity (with susceptibility unchanged) due to HC θ, from a baseline value of 1 to 4 in the direction
of the arrow. (c) Time series plot of HIV prevalence for increasing suceptibility (with infectivity constant) due to
HC use χ, from baseline value of 1 to 4 in the direction of the arrow. Prevalence increases in the cohort using HC
but remains unchanged in the general population since that population is very small. (d) Time series plot of HIV
prevalence as the population using condoms as birth control tool increases from 0%, 30% to 100% in the direction
of the arrow. Other parameter values are as given in Table 2
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Tables
Parameter PRCC p-value Parameter PRCC p-value
γ −0.997 < 0.001 cf 0.356 < 0.001
θ 0.726 < 0.001 ρfcm 0.093 0.352
cm 0.623 < 0.001 ρfnm −0.079 0.431
χ 0.577 < 0.001 pc 0.061 0.540
ρfhm 0.516 < 0.001 δ2 0.047 0.630
βf 0.522 < 0.001 δ3 −0.025 0.804
βm 0.400 < 0.001 δ1 −0.024 0.810
Table 1: The PRCCs are between the input parameter and the output values (total AIDS cases). The p-value
quantifies the probability that the result is due to chance rather than a true relationship between the input parameter
and the output variable.
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Symbol Parameter definition Range or baseline value Source of data Fitted value
Biological, epidemiological and demographic parameters
µ Natural death rate 0.02 [58, 59, 61] -
Λ Newly sexually matured individuals 100 000/yr [59] -
φ Proportion of new recruits who are female variable - -
α Emigration rate 0.01 [58–61] 0.055
(βf , βm) Probability of HIV transmission [0− 1] [15] (0.51, 0.8)
γ Average incubation period 0.125 [58–61] 0.095
(cf , cm) Frequency of partner acquisition 3[1− 13] partners/yr [5, 74] -
ν AIDS induced death rate 0.333 [58–61] -
̟ Response parameter for behaviour change > 0 - 3.78× 10−6
Birth control related parameters
δ1 Proportion of mature females who
use condoms for birth control variable [24] -
δ2 Proportion of mature females who
use natural methods for birth control variable [24] -
δ3 Proportion of mature females who use
HC methods for birth control variable [24] -
ρmfc Proportion of contacts made by males with
females who use condoms for birth control variable - -
ρmfn Proportion of contacts made by males with
females who use natural methods for birth control variable - -
ρmfh Proportion of contacts made by males with
females who use HC methods for birth control variable 0-1
χ Relative measure of increased susceptibility
of females who use HC methods of birth control ≥ 2 [28] -
θ Relative measure of increased infectivity
of females who use HC methods of birth control ≥ 2 [28] -
ǫ Condom efficacy 85%[85− 90]% [13,53] -
ψ Consistency of condom use 0− 25% [1,41] -
Table 2: Model parameters and their interpretation.
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